EXPERT REVIEW OF VACCINES

Published by Taylor & Francis Group

Open access · CC BY-NC · In DOAJ · United States · Immunotherapy and Immune Responses

Journal at a glance

ISSN

1476-0584

Publisher

Taylor & Francis Group

Country

United States

Language

en

License

CC BY-NC

Also known as: Expert Rev Vaccines (Abbreviation)

Indexing

• Web of Science (SCIE): Indexed
• DOAJ: Active
• Medline: Active
• Pubmed: Active

Metrics

Subjects

• Immunotherapy and Immune Responses
• Influenza Virus Research Studies
• Vaccine Coverage and Hesitancy
• Respiratory viral infections research
• Pneumonia and Respiratory Infections
• vaccines and immunoinformatics approaches
• SARS-CoV-2 and COVID-19 Research
• Medicine: Internal medicine

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Cost-effectiveness of RSVpreF for the prevention of respiratory syncytial virus illness among high-risk adults in Germany (2026)
• Modeling the public health impact of vaccination with Pfizer-BioNTech COVID-19 vaccine, LP.8.1, 2025–2026 formula in the pediatric population aged 5–17 years at high risk of severe outcomes from COVID-19 in the United States (2026)
• Epidemiological characteristics of varicella and factors associated with breakthrough varicella among children aged 0–14 years in Jiangsu Province, China (2026)
• Recent advances in the development of a vaccine to target meningococcal serogroup X (2026)
• Adapted XBB.1.5 vaccine effectiveness against severe COVID-19 outcomes among immunocompromised persons in 2023–24 in six European countries: a VEBIS-EHR network study (2026)

Similar journals

• Human Vaccines & Immunotherapeutics — United States · Open access · Same subject: Immunotherapy and Immune Responses, Same subject: Influenza Virus Research Studies, 6 shared subjects in total, Same country
• Vaccine — United Kingdom · — · Same subject: Immunotherapy and Immune Responses, Same subject: Influenza Virus Research Studies, 5 shared subjects in total
• Morbidity and Mortality Weekly Report — United States · Open access · Same subject: Influenza Virus Research Studies, Same subject: Respiratory viral infections research, 4 shared subjects in total, Same country
• Vaccine: X — Kingdom of the Netherlands · Open access · Same subject: Influenza Virus Research Studies, Same subject: Respiratory viral infections research, 4 shared subjects in total
• International Journal of Infectious Diseases — Kingdom of the Netherlands · Open access · Same subject: Pneumonia and Respiratory Infections, Same subject: Respiratory viral infections research, 3 shared subjects in total
• The Lancet Infectious Diseases — Kingdom of the Netherlands · — · Same subject: Pneumonia and Respiratory Infections, Same subject: Respiratory viral infections research, 3 shared subjects in total

Sources: DOAJ, OpenAlex, NLM Catalog, Crossref, Web of Science (Clarivate) · Last verified 2026-09-05

Journal homepage · Author guidelines